Skip to main content
Top
Published in: AIDS and Behavior 6/2013

Open Access 01-07-2013 | Original Paper

A Randomized Controlled Trial Examining the Efficacy of Motivational Counseling with Observed Therapy for Antiretroviral Therapy Adherence

Authors: Kathy Goggin, Mary M. Gerkovich, Karen B. Williams, Julie W. Banderas, Delwyn Catley, Jannette Berkley-Patton, Glenn J. Wagner, James Stanford, Sally Neville, Vinutha K. Kumar, David M. Bamberger, Lisa A. Clough

Published in: AIDS and Behavior | Issue 6/2013

Login to get access

Abstract

This study determined whether motivational interviewing-based cognitive behavioral therapy (MI-CBT) adherence counseling combined with modified directly observed therapy (MI-CBT/mDOT) is more effective than MI-CBT counseling alone or standard care (SC) in increasing adherence over time. A three-armed randomized controlled 48-week trial with continuous electronic drug monitored adherence was conducted by randomly assigning 204 HIV-positive participants to either 10 sessions of MI-CBT counseling with mDOT for 24 weeks, 10 sessions of MI-CBT counseling alone, or SC. Poisson mixed effects regression models revealed significant interaction effects of intervention over time on non-adherence defined as percent of doses not-taken (IRR = 1.011, CI = 1.000–1.018) and percent of doses not-taken on time (IRR = 1.006, CI = 1.001–1.011) in the 30 days preceding each assessment. There were no significant differences between groups, but trends were observed for the MI-CBT/mDOT group to have greater 12 week on-time and worse 48 week adherence than the SC group. Findings of modest to null impact on adherence despite intensive interventions highlights the need for more effective interventions to maintain high adherence over time.
Literature
1.
go back to reference Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194–200.PubMedCrossRef Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194–200.PubMedCrossRef
2.
go back to reference Jones J, Taylor B, Wilkin TJ, et al. Advances in antiretroviral therapy. Top HIV Med. 2007;15:48–83.PubMed Jones J, Taylor B, Wilkin TJ, et al. Advances in antiretroviral therapy. Top HIV Med. 2007;15:48–83.PubMed
3.
go back to reference Palella FJ, Chmiel JS, Moorman AC, et al. Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients. AIDS. 2002;16:1617–26.CrossRef Palella FJ, Chmiel JS, Moorman AC, et al. Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients. AIDS. 2002;16:1617–26.CrossRef
4.
go back to reference Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15:1381–96.PubMedCrossRef Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15:1381–96.PubMedCrossRef
6.
go back to reference Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41:285–97.PubMedCrossRef Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41:285–97.PubMedCrossRef
7.
go back to reference Hill S, Kavookjian J. Motivational interviewing as a behavioral intervention to increase HAART adherence in patients who are HIV-positive: a systematic review of the literature. AIDS Care. 2012;24:583–92.PubMedCrossRef Hill S, Kavookjian J. Motivational interviewing as a behavioral intervention to increase HAART adherence in patients who are HIV-positive: a systematic review of the literature. AIDS Care. 2012;24:583–92.PubMedCrossRef
8.
go back to reference Simoni JM, Pearson CR, Pantalone DW, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43:S23–35.PubMedCrossRef Simoni JM, Pearson CR, Pantalone DW, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43:S23–35.PubMedCrossRef
9.
go back to reference DiIorio C, Resnicow K, McDonnell M, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. J Assoc Nurses AIDS Care. 2003;14:52.PubMedCrossRef DiIorio C, Resnicow K, McDonnell M, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. J Assoc Nurses AIDS Care. 2003;14:52.PubMedCrossRef
10.
go back to reference Golin C, Earp J, Tien HC, et al. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42:42–51.PubMedCrossRef Golin C, Earp J, Tien HC, et al. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42:42–51.PubMedCrossRef
11.
go back to reference Pradier C, Bentz L, Spire B, et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003;4:121–31.PubMedCrossRef Pradier C, Bentz L, Spire B, et al. Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials. 2003;4:121–31.PubMedCrossRef
12.
go back to reference Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-Steps and medication monitoring. Behav Res Ther. 2001;39:1151–62.PubMedCrossRef Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-Steps and medication monitoring. Behav Res Ther. 2001;39:1151–62.PubMedCrossRef
13.
go back to reference Altice FL, Maru DS, Bruce RD, et al. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis. 2007;45:770–8.PubMedCrossRef Altice FL, Maru DS, Bruce RD, et al. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis. 2007;45:770–8.PubMedCrossRef
14.
go back to reference Pearson CR, Micek MA, Simoni JM, et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr. 2007;46:238–44.PubMedCrossRef Pearson CR, Micek MA, Simoni JM, et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr. 2007;46:238–44.PubMedCrossRef
15.
go back to reference Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community based directly observed therapy as an adherence intervention for HAART among substance abusers. AIDS. 2007;21:1473–7.PubMedCrossRef Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community based directly observed therapy as an adherence intervention for HAART among substance abusers. AIDS. 2007;21:1473–7.PubMedCrossRef
16.
go back to reference Hart JE, Jeon CY, Ivers LC, Behforouz HL, Caldas A, Drobac PC, Shin SS. Effect of directly observed therapy for highly active antiretroviral therapy on virologic immunologic, and adherence outcomes: a meta-analysis and systematic review. J Acquir Immune Defic Syndr. 2010;54–2:167–79. Hart JE, Jeon CY, Ivers LC, Behforouz HL, Caldas A, Drobac PC, Shin SS. Effect of directly observed therapy for highly active antiretroviral therapy on virologic immunologic, and adherence outcomes: a meta-analysis and systematic review. J Acquir Immune Defic Syndr. 2010;54–2:167–79.
17.
go back to reference Ford N, Nachega JB, Engel ME, Mills EJ. Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. Lancet. 2009;374–9707:2064–71.CrossRef Ford N, Nachega JB, Engel ME, Mills EJ. Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. Lancet. 2009;374–9707:2064–71.CrossRef
18.
go back to reference Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11–9.PubMedCrossRef Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194:11–9.PubMedCrossRef
19.
go back to reference Beck JS. Cognitive therapy: basics and beyond. New York: The Guilford Press; 1995. Beck JS. Cognitive therapy: basics and beyond. New York: The Guilford Press; 1995.
20.
go back to reference Goggin K, Liston R, Mitty JA. Modified directly observed therapy for ART: a primer from the field. Public Health Rep. 2007;122:472–81.PubMed Goggin K, Liston R, Mitty JA. Modified directly observed therapy for ART: a primer from the field. Public Health Rep. 2007;122:472–81.PubMed
21.
go back to reference Grant KA, Tonigan JS, Miller WR. Comparison of three alcohol consumption measures: a concurrent validity study. J Stud Alcohol. 1995;56(2):168–72.PubMed Grant KA, Tonigan JS, Miller WR. Comparison of three alcohol consumption measures: a concurrent validity study. J Stud Alcohol. 1995;56(2):168–72.PubMed
22.
go back to reference Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef
23.
go back to reference Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004;39:609–29.PubMedCrossRef Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004;39:609–29.PubMedCrossRef
26.
go back to reference Banderas J, Thomson D, Gerkovich M, et al. Value of multi-modal standard care assessment in ART adherence research. In: 5th NIMH/IAPAC International Conference on HIV Treatment Adherence, Miami, 2010. Banderas J, Thomson D, Gerkovich M, et al. Value of multi-modal standard care assessment in ART adherence research. In: 5th NIMH/IAPAC International Conference on HIV Treatment Adherence, Miami, 2010.
27.
go back to reference Miller W, Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. New York: Guilford Press; 2002. Miller W, Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. New York: Guilford Press; 2002.
29.
go back to reference Harris KJ, Catley D, Good GE, et al. Motivational Interviewing for smoking cessation in college students: a group randomized controlled trial. Prev Med. 2010;51:387–93.PubMedCrossRef Harris KJ, Catley D, Good GE, et al. Motivational Interviewing for smoking cessation in college students: a group randomized controlled trial. Prev Med. 2010;51:387–93.PubMedCrossRef
30.
go back to reference Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: poisson, overdispersed Poisson, and negative binomial models. Psychol Bull. 1995;118(3):392–404.PubMedCrossRef Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: poisson, overdispersed Poisson, and negative binomial models. Psychol Bull. 1995;118(3):392–404.PubMedCrossRef
31.
go back to reference Simoni JM, Amico KR, Smith L, et al. Antiretroviral adherence interventions: translating research findings to the real world clinic. Current HIV/AIDS Rep. 2010;7:44–51.CrossRef Simoni JM, Amico KR, Smith L, et al. Antiretroviral adherence interventions: translating research findings to the real world clinic. Current HIV/AIDS Rep. 2010;7:44–51.CrossRef
32.
go back to reference Sarna A, Luchters S, Geibel S, et al. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial. J Acquir Immune Defic Syndr. 2008;48–5:611–9.CrossRef Sarna A, Luchters S, Geibel S, et al. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial. J Acquir Immune Defic Syndr. 2008;48–5:611–9.CrossRef
33.
go back to reference Chung MH, Richardson BA, Tapia K, et al. A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS Med. 2011;8(3):e1000422.PubMedCrossRef Chung MH, Richardson BA, Tapia K, et al. A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes. PLoS Med. 2011;8(3):e1000422.PubMedCrossRef
34.
go back to reference Parsons JT, Golub SA, Rosof E, et al. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46(4):443–50.PubMedCrossRef Parsons JT, Golub SA, Rosof E, et al. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46(4):443–50.PubMedCrossRef
35.
go back to reference Safren SA, O’Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1–10.PubMedCrossRef Safren SA, O’Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1–10.PubMedCrossRef
36.
go back to reference Samet JH, Horton NJ, Meli S, et al. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther. 2005;10:83–93.PubMed Samet JH, Horton NJ, Meli S, et al. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther. 2005;10:83–93.PubMed
37.
go back to reference Wagner GJ, Kanouse DE, Golinelli D, et al. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006;20:1295–302.PubMedCrossRef Wagner GJ, Kanouse DE, Golinelli D, et al. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006;20:1295–302.PubMedCrossRef
38.
go back to reference Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25:1138–9.CrossRef Pop-Eleches C, Thirumurthy H, Habyarimana JP, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011;25:1138–9.CrossRef
39.
go back to reference Haberer JE, Kahane J, Kigozi I, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14(6):1340–6.PubMedCrossRef Haberer JE, Kahane J, Kigozi I, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14(6):1340–6.PubMedCrossRef
40.
go back to reference Gustafson DH, Shaw BR, Isham A, Baker T, Boyle MG, Levy M. Explicating an evidence-based, theoretically informed, mobile technology-based system to improve outcomes for people in recovery for alcohol dependence. Subst Use Misuse. 2011;46(1):96–111.PubMedCrossRef Gustafson DH, Shaw BR, Isham A, Baker T, Boyle MG, Levy M. Explicating an evidence-based, theoretically informed, mobile technology-based system to improve outcomes for people in recovery for alcohol dependence. Subst Use Misuse. 2011;46(1):96–111.PubMedCrossRef
41.
go back to reference Rasu R, Malewski D, Thomson N, et al. Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2013;63:e1–e8.PubMedCrossRef Rasu R, Malewski D, Thomson N, et al. Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2013;63:e1–e8.PubMedCrossRef
42.
go back to reference Lima VD, Bangsberg DR, Harrigan PR, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr. 2010;55(4):460–5.PubMedCrossRef Lima VD, Bangsberg DR, Harrigan PR, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr. 2010;55(4):460–5.PubMedCrossRef
43.
go back to reference Bangsberg DR. Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patients. Curr HIV/AIDS Rep. 2009;6(4):173–4.PubMedCrossRef Bangsberg DR. Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patients. Curr HIV/AIDS Rep. 2009;6(4):173–4.PubMedCrossRef
Metadata
Title
A Randomized Controlled Trial Examining the Efficacy of Motivational Counseling with Observed Therapy for Antiretroviral Therapy Adherence
Authors
Kathy Goggin
Mary M. Gerkovich
Karen B. Williams
Julie W. Banderas
Delwyn Catley
Jannette Berkley-Patton
Glenn J. Wagner
James Stanford
Sally Neville
Vinutha K. Kumar
David M. Bamberger
Lisa A. Clough
Publication date
01-07-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0467-3

Other articles of this Issue 6/2013

AIDS and Behavior 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine